DE602006020611D1 - Krebsbehandlungsverfahren - Google Patents
KrebsbehandlungsverfahrenInfo
- Publication number
- DE602006020611D1 DE602006020611D1 DE602006020611T DE602006020611T DE602006020611D1 DE 602006020611 D1 DE602006020611 D1 DE 602006020611D1 DE 602006020611 T DE602006020611 T DE 602006020611T DE 602006020611 T DE602006020611 T DE 602006020611T DE 602006020611 D1 DE602006020611 D1 DE 602006020611D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment method
- cancer treatment
- cancer
- administration
- relates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74030805P | 2005-11-29 | 2005-11-29 | |
| PCT/US2006/045777 WO2007064753A2 (en) | 2005-11-29 | 2006-11-29 | Cancer treatment method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006020611D1 true DE602006020611D1 (de) | 2011-04-21 |
Family
ID=37847172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006020611T Active DE602006020611D1 (de) | 2005-11-29 | 2006-11-29 | Krebsbehandlungsverfahren |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090005406A1 (de) |
| EP (2) | EP2380572A1 (de) |
| JP (1) | JP2009517397A (de) |
| AT (1) | ATE500831T1 (de) |
| CY (1) | CY1111390T1 (de) |
| DE (1) | DE602006020611D1 (de) |
| DK (1) | DK1954281T3 (de) |
| ES (1) | ES2359517T3 (de) |
| HR (1) | HRP20110244T1 (de) |
| PL (1) | PL1954281T3 (de) |
| SI (1) | SI1954281T1 (de) |
| WO (1) | WO2007064753A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2058307A1 (de) | 2007-11-12 | 2009-05-13 | Cellzome Ag | Verfahren zur Identifizierung von mit JAK-Kinase wechselwirkenden Molekülen und zur JAK-Kinase-Reinigung |
| WO2011050159A1 (en) * | 2009-10-23 | 2011-04-28 | Glaxo Wellcome Manufacturing Pte Ltd | Compositions and processes |
| WO2011058179A1 (en) | 2009-11-16 | 2011-05-19 | Ratiopharm Gmbh | 5- (4- (n- (2, 3 -dimethyl- 2h- indazol- 6 -yl) -n-methylamino) pyrimidin- 2 -ylamino) -2 -methylbenzenesulfonamide |
| WO2011069053A1 (en) | 2009-12-04 | 2011-06-09 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of pazopanip hcl and crystalline forms of pazopanib hcl |
| US20130197016A1 (en) | 2010-10-27 | 2013-08-01 | Mitchell Brigell | Dosing regimes for the treatment of ocular vascular disease |
| AU2012332952B2 (en) | 2011-10-31 | 2016-05-05 | Novartis Ag | Pazopanib formulation |
| US20150335609A1 (en) * | 2012-02-17 | 2015-11-26 | Pharmacyclics, Inc. | Combinations of histone deacetylase inhibitor and pazopanib and uses thereof |
| CN103319410B (zh) * | 2012-03-22 | 2016-04-06 | 天津药物研究院 | 一种吲唑化合物的合成方法 |
| CN103232443B (zh) * | 2013-02-01 | 2014-12-10 | 天津药物研究院 | 一种吲唑衍生物的晶型及其制备和用途 |
| WO2015068175A2 (en) | 2013-11-05 | 2015-05-14 | Laurus Labs Private Limited | An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof |
| CN110878089A (zh) * | 2018-09-05 | 2020-03-13 | 江苏豪森药业集团有限公司 | 一种盐酸帕唑帕尼的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100847169B1 (ko) | 2000-12-21 | 2008-07-17 | 글락소 그룹 리미티드 | 혈관형성 조절제로서의 피리미딘아민 |
| DE60203260T2 (de) | 2001-01-16 | 2006-02-02 | Glaxo Group Ltd., Greenford | Pharmazeutische kombination, die ein 4-chinazolinamin und paclitaxel, carboplatin oder vinorelbin enthält, zur behandlung von krebs |
| CN1688553A (zh) | 2002-06-17 | 2005-10-26 | 史密丝克莱恩比彻姆公司 | 化学方法 |
| WO2005105094A2 (en) * | 2004-04-16 | 2005-11-10 | Smithkline Beecham Corporation | Cancer treatment method |
-
2006
- 2006-11-29 JP JP2008542487A patent/JP2009517397A/ja active Pending
- 2006-11-29 DK DK06838636.6T patent/DK1954281T3/da active
- 2006-11-29 EP EP10194774A patent/EP2380572A1/de not_active Withdrawn
- 2006-11-29 WO PCT/US2006/045777 patent/WO2007064753A2/en active Application Filing
- 2006-11-29 DE DE602006020611T patent/DE602006020611D1/de active Active
- 2006-11-29 PL PL06838636T patent/PL1954281T3/pl unknown
- 2006-11-29 ES ES06838636T patent/ES2359517T3/es active Active
- 2006-11-29 AT AT06838636T patent/ATE500831T1/de active
- 2006-11-29 US US12/094,687 patent/US20090005406A1/en not_active Abandoned
- 2006-11-29 EP EP06838636A patent/EP1954281B1/de active Active
- 2006-11-29 SI SI200631005T patent/SI1954281T1/sl unknown
-
2011
- 2011-04-04 HR HR20110244T patent/HRP20110244T1/hr unknown
- 2011-04-18 CY CY20111100387T patent/CY1111390T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007064753A2 (en) | 2007-06-07 |
| ATE500831T1 (de) | 2011-03-15 |
| EP1954281B1 (de) | 2011-03-09 |
| US20090005406A1 (en) | 2009-01-01 |
| PL1954281T3 (pl) | 2011-07-29 |
| JP2009517397A (ja) | 2009-04-30 |
| WO2007064753A3 (en) | 2007-11-29 |
| SI1954281T1 (sl) | 2011-06-30 |
| ES2359517T3 (es) | 2011-05-24 |
| DK1954281T3 (da) | 2011-05-16 |
| CY1111390T1 (el) | 2015-08-05 |
| EP2380572A1 (de) | 2011-10-26 |
| HRP20110244T1 (hr) | 2011-04-30 |
| EP1954281A2 (de) | 2008-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006020611D1 (de) | Krebsbehandlungsverfahren | |
| EA200970575A1 (ru) | Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения | |
| DK1968594T3 (da) | Behandling af okulære neovaskulære lidelser, såsom makulær degeneration, striae angioides og makulært ødem | |
| NO2010020I1 (no) | 5-{{4-[(2,3-dimetyl-2H-indazot-6-yl)(metyl)amino]pyrimidin-2-yl}amino)-2-metylbenzensulfonamid Pazopanib. | |
| NZ594385A (en) | Aminopyrimidines useful as kinase inhibitors | |
| NO20074431L (no) | Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer | |
| ATE466580T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
| ATE468336T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
| ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
| PE20081800A1 (es) | NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA | |
| PL406680A1 (pl) | Inhibitory kinaz tyrozynowych | |
| EA200501333A1 (ru) | 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ | |
| NO20081592L (no) | Dipeptidylpeptidaseinhibitorer for behandling av diabetes | |
| DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
| CY1111489T1 (el) | Ενωσεις για την αναστολη του πρωτεασωματος | |
| NO20070453L (no) | Kondenserte heterocykliske kinase inhibitorer | |
| EP1764092A3 (de) | Therapeutische strategien für die prävention und behandlung der alzeheimer-krankheit | |
| DK3449934T3 (da) | Behandling af glycogenlagringssygdom type II | |
| DK1926729T3 (da) | Benzothiazolcyclobutylaminderivater og deres anvendelse som histamin-3-receptorligander | |
| DE602006017574D1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
| WO2007143483A3 (en) | Combination of pazopanib and lapatinib for treating cancer | |
| EA200702027A1 (ru) | Дерматологические композиции и соли для лечения дерматологических заболеваний | |
| ATE435858T1 (de) | Prodrugs von als erk-proteinkinase-inhibitoren wirkenden pyrrolylpyrimidinen | |
| EA200900034A1 (ru) | Применение ингибитора р38 киназы для лечения психиатрических расстройств | |
| EA200701584A1 (ru) | Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения |